Patents by Inventor Jiujiu Yu

Jiujiu Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9422368
    Abstract: The present invention relates to agents that are non-competitive antagonists of the CD94/NKG2A receptor such as certain anti-NKG2A antibodies, in particular humanized versions of murine anti-NKG2A antibody Z199, as well as methods of producing and using such agents and antibodies.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: August 23, 2016
    Assignee: NOVO NORDISK A/S
    Inventors: Petrus Johannes Louis Spee, Jianhe Chen, Soren Berg Padkjaer, Jing Su, Jinchao Zhang, Jiujiu Yu
  • Publication number: 20140341896
    Abstract: The present invention relates to agents that are non-competitive antagonists of the CD94/NKG2A receptor such as certain anti-NKG2A antibodies, in particular humanized versions of murine anti-NKG2A antibody Z199, as well as methods of producing and using such agents and antibodies.
    Type: Application
    Filed: August 1, 2014
    Publication date: November 20, 2014
    Inventors: PETRUS JOHANNES LOUIS SPEE, JIANHE CHEN, SOREN BERG PADKJAER, JING SU, JINCHAO ZHANG, JIUJIU YU
  • Patent number: 8796427
    Abstract: The present invention relates to agents that are non-competitive antagonists of the CD94/NKG2A receptor such as certain anti-NKG2A antibodies, in particular humanized versions of murine anti-NKG2A antibody Z199, as well as methods of producing and using such agents and antibodies.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: August 5, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Petrus Johannes Louis Spee, Jianhe Chen, Søren Berg Padkjær, Jing Su, Jinchao Zhang, Jiujiu Yu
  • Publication number: 20110052606
    Abstract: The present invention relates to agents that are non-competitive antagonists of the CD94/NKG2A receptor such as certain anti-NKG2A antibodies, in particular humanized versions of murine anti-NKG2A antibody Z199, as well as methods of producing and using such agents and antibodies.
    Type: Application
    Filed: January 23, 2009
    Publication date: March 3, 2011
    Inventors: Petrus Johannes Louis Spee, Jianhe Chen, Søren Berg Padkjaer, Jing Su, Jinchao Zhang, Jiujiu Yu